Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blaine Labs, operating under the brand Dr. Blaine's, is a pharmaceutical and medical device company specializing in the development and manufacturing of FDA-cleared topical treatments. The company primarily focuses on podiatry and dermatology, offering a range of products for conditions such as fungal infections, scarring, and chronic dry skin. Their portfolio includes well-known brands like Tineacide, RevitaDerm, and ScarCure, which are distributed through medical professionals and retail channels. Blaine Labs maintains in-house manufacturing and research capabilities to support its line of over-the-counter and prescription-strength solutions. The company was acquired by the private equity firm The Riverside Company in 2020 to accelerate its growth and product development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr. Blaine's.